AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ASPIRIN , CAFFEINE

11 registrations across 5 African markets— 7 active

Markets with ASPIRIN , CAFFEINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
Child Cafemol tablets
Tablet Uncoated
🇿🇲ZambiaPharmanova Zambia LimitedactiveNov 2029
Mr. Power 500 tablets
Tablet Uncoated
🇿🇲ZambiaVardhman Exports LtdactiveMay 2029
NOPAYNE
TABLET; ORAL
🇿🇼ZimbabweCAPS PVT LTDactiveDec 2027
PAIN-EEZE
TABLET; ORAL
🇿🇼ZimbabwePHARMANOVA PVT LTDactiveDec 2027
ENPAIN TABLETS🇬🇭GhanaexpiredOct 2026
ENPAIN TABLETS🇬🇭GhanaactiveOct 2026
ENPAIN TABLETS🇬🇭GhanaactiveOct 2026
CAFEMOL- COMBINATION PRODUCT TABLET
TABLET
🇲🇼MalawiexpiredMar 2025
PAINEEZE COMBINATION PRODUCT TABLET
TABLET
🇲🇼MalawiexpiredMar 2024
MIFUPEN 350MG/30MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2022
Mifupen
Tablets
🇹🇿TanzaniaELYS CHEMICAL INDUSTRIES LTDactive

ASPIRIN , CAFFEINE in Africa — Regulatory Overview

ASPIRIN , CAFFEINE is registered across 5 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Malawi, Zambia, Zimbabwe and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 7 (64%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.